Suppressing the activation of IL-1β which is controlled by NLRP3 inflammasome, protects transgenic models of AD by effectively stopping the subsequent production of IL-1β, which plays a pivotal role in triggering inflammatory reactions in the brain (Zahid et al., 2019). Here, NLRP3 is linked to Alzheimer disease.